Safe, Compliant and Efficient: Meeting the Pharmaceutical Challenge End-to-End
The Client
Enablon, a Wolters Kluwer business, is a leading company in risk management, EHS and sustainability software solutions.
The Brief
The pharmaceutical industry is a key target for Enablon. In the wake of COVID-19, over the last year, solving the complexities of safety, compliance and efficiency within pharmaceutical companies is more imper ative than ever before. For the largest brands, having an expert such as Enablon to deliver software solutions and risk management to resolve these challenges is integral.
In order to target such C-suite accounts within the pharmaceutical industry, Enablon needed assistance in tuning their message and creating engaging assets that would achieve this.
The Solution
We produced a professionally designed eBook, to reflect the nature of the leading pharmaceutical companies, whilst keeping in line with Enablon’s branding.
Throughout this digital asset, we outlined the challenges that the pharmaceutical industry was facing, as well as their opportunities and Enablon’s solutions for them.
The eBook focused largely on Enablon’s business imperatives of end-to-end pharmaceuticals: safety, compliance and efficiency.
An integrated infographic was also delivered.
Within this asset, we walk through the pharmaceutical plant end-to-end, highlighting the challenges that they may face within the 3 pillars of safety, compliance and efficiency, and how Enablon was able to provide solutions for each.
We also produced email copy for each of the 3 pillars: safety, compliance and efficiency. This copy was produced in order to target those C-suite level accounts for Enablon.
Finally, we also provided copy for their website, that promoted the eBook asset, with a CTA to download it.
